Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion type Assertion NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_head.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion description "[Although GCIP has little inhibition on the number of hepatic tumors at later stages (40 weeks), hepatocellular tumors in GCIP transgenic mice are smaller and well-differentiated compared to the poorly differentiated tumors in wild-type mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_provenance.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion evidence source_evidence_literature NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_provenance.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion SIO_000772 16501603 NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_provenance.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion wasDerivedFrom befree-20140225 NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_provenance.
- NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_assertion wasGeneratedBy ECO_0000203 NP492706.RAZWGW5JEs2E0tikfwu4_2FI0nGBMLpmXaB_yD2TGLaX4130_provenance.